# A Study To Assess The Safety Of PF-06342674 In Healthy Volunteers

> **NCT01740609** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 80 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Placebo
- **BIOLOGICAL:** PF-06342674 Dose A
- **BIOLOGICAL:** PF-06342674 Dose B
- **BIOLOGICAL:** PF-06342674 Dose C
- **BIOLOGICAL:** PF-06342674 Dose D
- **BIOLOGICAL:** PF-06342674 Dose E
- **BIOLOGICAL:** PF-06342674 Dose F
- **BIOLOGICAL:** PF-06342674 Dose G
- **BIOLOGICAL:** PF-06342674 Dose H
- **BIOLOGICAL:** PF-06342674 Dose I
- **BIOLOGICAL:** PF-06342674 Dose J

## Key facts

- **NCT ID:** NCT01740609
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2014-06-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01740609

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01740609, "A Study To Assess The Safety Of PF-06342674 In Healthy Volunteers". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01740609. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*